Crossmark

Efficacy and Safety of Tyrosine Kinase Inhibitors in Downstaging and Palliation in Patients with Advanced Differentiated Thyroid Cancer — A Multicentre study

Crossref DOI link: https://doi.org/10.1007/s13193-024-02053-2

Published Online: 2024-08-09

Published Print: 2025-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Bhat, Ganesh

Chanthar, Vishvak K. M. M.

Rahalkar, Ashwinee

Sooraj, Rizhin

Philip, Ranjith Cheriyan

Mayilvaganan, Sabaretnam

Singh, Kul Ranjan

Chand, Gyan

Ramakant, Pooja https://orcid.org/0000-0002-6503-1727
Mishra, Anjali

Agarwal, Gaurav

Paul, Jacob Mazhuvanchary

Mishra, Anand Kumar
License Information

Text and Data Mining valid from 2024-08-09

Version of Record valid from 2024-08-09
More Information

Article History

Received: 17 May 2024

Accepted: 21 July 2024

First Online: 9 August 2024

Declarations

:

: Ethical clearance was obtained from all three participating universities.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below